Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

5.7K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
5.7K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

5.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.5K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

2.8K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
2.8K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

3.4K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

5.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

3.3K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

FOXC2 represses NFAT1-dependent transcription through a DNA-facilitated protein-protein interaction.

Nucleic acids research·2026
Same author

Molecular mechanisms underlying HRK interaction with BCL-XL and BCL-2 reveal specificity determinants for BH3 mimetics.

iScience·2025
Same author

Deciphering molecular specificity in MCL-1/BAK interaction and its implications for designing potent MCL-1 inhibitors.

Cell death and differentiation·2025
Same author

Characterization of Bozitinib as a potential therapeutic agent for MET-amplified gastric cancer.

Communications biology·2025
Same author

Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4.

European journal of medicinal chemistry·2024
Same author

Structural characterization of the DNA binding mechanism of retinoic acid-related orphan receptor gamma.

Structure (London, England : 1993)·2024

相关实验视频

Updated: May 16, 2025

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

10.8K

对亡性MCL1-HRK复合物的结构分析.

Jiaqi Wang1, Longying Jiang2, Hudie Wei1

  • 1Department of Oncology, NHC Key Laboratory of Cancer Proteomics & State Local Joint Engineering Laboratroy for Anticancer Drugs, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.

Biochemical and biophysical research communications
|May 9, 2025
PubMed
概括
此摘要是机器生成的。

哈拉基里 (HRK) BH3与髓状细胞白血病1 (MCL1) 结合,这是一种对癌细胞存活至关重要的抗亡蛋白. 了解这种相互作用为开发新的BH3模仿癌症疗法提供了洞察力.

关键词:
在BCL-2家族中.BH3模仿的是 BH3 的模仿.哈拉基里 (Harakiri) 是一个城市.骨髓细胞白血病 1 1

更多相关视频

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.2K
Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
09:15

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells

Published on: October 20, 2022

2.1K

相关实验视频

Last Updated: May 16, 2025

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
08:55

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis

Published on: August 7, 2018

10.8K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

3.2K
Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
09:15

Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells

Published on: October 20, 2022

2.1K

科学领域:

  • 分子生物学分子生物学
  • 结构生物学 结构生物学
  • 癌症治疗方法 癌症治疗方法

背景情况:

  • 骨髓细胞白血病1 (MCL1) 是BCL-2家族的抗亡蛋白,对恶性细胞存活至关重要.
  • 用BH3模仿剂准MCL1是一种有前途的抗癌策略.
  • 哈拉基里 (HRK) 是一种仅为BH3的亲细胞亡蛋白.

研究的目的:

  • 在生物化学和结构上描述HRK BH3和MCL1.1之间的相互作用.
  • 为MCL1-向BH3模拟器的合理设计提供见解.

主要方法:

  • 生物化学结合试验以确定结合亲和力 (EC50).
  • 通过X射线晶体学以1.4 Å分辨率解析复杂结构.
  • 蛋白质 - 配体相互作用的结构分析.

主要成果:

  • HRK BH3对MCL1 (EC50 = 42.7 nM) 显示了中度的亲和力.
  • 晶体结构显示了α-螺旋式HRK BH3与MCL1.1的规范性疏水槽结合.
  • 确定了与MCL1的特定残留物相互作用 (白,三,K38,D42),包括静电和结合.

结论:

  • 这项研究阐明了HRK BH3与MCL1.1结合的分子基础.
  • 详细的结构洞察力有助于进一步了解MCL1的抗亡功能.
  • 这些发现为优化BH3模仿剂用于癌症治疗提供了基础.